Manufacturing

Lisete Pinto is Product Development and Technical Support senior manager at Recipharm.

Articles

In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.

Addressing the Key Pitfalls Hindering Technology Transfer Success

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

Societal CDMO Signs Multiple CDMO Service Agreements

Luc Gagnon, PhD, is vice-president of Vaccine Sciences at Nexelis.

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.

The Key Elements for Assay Transfer Success

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

Honeywell Completes Remote Control System Migration for Hungarian Pharma Manufacturer

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.

AbCellera’s Acquisition of OrthoMab Bispecific Platform Propels Antibody Development

The companies have formed a collaboration to develop a novel human recombinant protein as a therapeutic candidate against COVID-19.


Airway Therapeutics, Celonic Group Partner on New COVID-19 Therapeutic

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.

Ensuring Smooth Tech Transfer of Bioprocess Operations

Shreekant Karmarkar, PhD, is president, DAT Pharma Consulting, Inc., skarmarkar@DATPharmaConsulting.com, 1-224-383-4493

How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.

Building Strategic Relationships with CROs

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.